arrow
M

Matej Orešič

orebro university
H指数:106
被引数:4.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DB06 Gut Microbiota Alterations and Microbiota-Derived Indole-3-Carboxaldehyde Are Associated with MASLD

DB06 肠道菌群改变及菌群衍生的3-羧醛吲哚与MASLD相关

2026-08-270
OAAI
EP497 - ECE_3829 - Evaluating steroid profiles through sexual dimorphism to define metabolic phenotypes and identify advanced fibrosis in patients with MASLD

EP497 - ECE_3829 - 通过性二态性评估类固醇谱以定义代谢表型并识别MASLD患者的进展性肝纤维化

2026-08-100
OAAI
A short-term randomized clinical trial testing feasibility of and physiological responses to a Ruminococcus torques strain in healthy overweight humans

一项短期随机临床试验,测试鲁米诺球菌鲁米诺科鲁斯菌株在健康超重人群中的可行性及生理反应

2026-07-160
OA
A lipidomics roadmap: from basic research to societal challenges

脂质组学路线图:从基础研究到社会挑战

2026-05-280
OAAI
Therapeutic TG2 inhibition reverses systemic multiomic dysregulation in celiac disease

治疗性TG2抑制可逆转乳糜泻的系统多组学失调

2026-04-240
OAAI
Microbiome-derived bile acid signatures in early life and their association with islet autoimmunity

微生物组衍生的胆汁酸特征与早期生命中的胰岛自身免疫相关性

2025-12-030
OAAI
Progressive Fibrosis in Human MASLD is Associated with Spatially Linked Transcriptomic Signatures of Metabolic Reprogramming and Senescence

人类MASLD的进行性纤维化与空间关联的代谢重编程和衰老转录组特征相关

2025-11-040
OAAI
Prenatal exposure to perfluoroalkyl substances predicts multimodal brain structural and functional outcomes in children aged 5 years: a birth cohort study

孕期全氟烷基物质暴露可预测5岁儿童多模态脑结构与功能结局:一项出生队列研究

2025-10-100
OAAI
Dynamics of Gut Metabolome and Microbiota Maturation during Early Life

肠道代谢组学和微生物群在早期生命中的动态成熟过程

2025-09-250
OAAI
Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial

大麻二酚能否减轻精神分裂症患者使用大麻的不良反应?一项随机、双盲、交叉试验

2025-07-240
OAAI